Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

Research output: Contribution to journalJournal articleResearchpeer-review

Both sublingual allergen-specific immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) have a documented clinical efficacy, but only few comparative studies have been performed.
Original languageEnglish
JournalAllergy
Volume59
Issue number1
Pages (from-to)45-53
Number of pages9
ISSN0105-4538
Publication statusPublished - Jan 2004

    Research areas

  • Administration, Sublingual, Adult, Allergens, Anti-Allergic Agents, Betula, Cross-Over Studies, Desensitization, Immunologic, Double-Blind Method, Female, Follow-Up Studies, Humans, Injections, Subcutaneous, Male, Middle Aged, Pollen, Probability, Reference Values, Rhinitis, Allergic, Seasonal, Risk Assessment, Statistics, Nonparametric, Treatment Outcome

ID: 50844892